About Sofar
Sofar is a company based in Trezzano Rosa (Italy) founded in 1968 was acquired by Alfasigma in August 2022. It operates as a Professional Services. Sofar has raised $52.35 thousand across 1 funding round from investors including Alfasigma. Sofar offers products and services including Pharmaceutical Production. Sofar operates in a competitive market with competitors including Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others.
- Headquarter Trezzano Rosa, Italy
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sofar S.P.A.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sofar
Sofar offers a comprehensive portfolio of products and services, including Pharmaceutical Production. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Pharmaceutical products are manufactured for health sector needs.
Funding Insights of Sofar
Sofar has successfully raised a total of $52.35K through 1 strategic funding round. The most recent funding activity was a Unspecified round of $52.35 thousand completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Unspecified — $52,350
-
First Round
First Round
(15 May 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2019 | Amount | Unspecified - Sofar | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sofar
Sofar has secured backing from 1 investor. Prominent investors backing the company include Alfasigma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Generic tablets, capsules, syrups, and injectables are manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sofar
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sofar
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sofar Comparisons
Competitors of Sofar
Sofar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jubilant Life Sciences, Recipharm, Akums, Unither and Nectar Lifesciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| domain | founded_year | HQ Location |
CDMO with a focus on early phase drug product development
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sofar
Frequently Asked Questions about Sofar
When was Sofar founded?
Sofar was founded in 1968 and raised its 1st funding round 51 years after it was founded.
Where is Sofar located?
Sofar is headquartered in Trezzano Rosa, Italy. It is registered at Trezzano Rosa, Lombardy, Italy.
Who is the current CEO of Sofar?
Andrea Biffi is the current CEO of Sofar.
Is Sofar a funded company?
Sofar is a funded company, having raised a total of $52.35K across 1 funding round to date. The company's 1st funding round was a Unspecified of $52.35K, raised on May 15, 2019.
What does Sofar do?
Sofar S.p.A. is focused on pharmaceutical production and operates as a Contract Development and Manufacturing Organization (CDMO). The commercial branch of Sofar S.p.A. was transferred to Alfasigma S.p.A. as of February 1, 2023. The company continues to serve the healthcare sector by providing manufacturing solutions and maintaining compliance with legal and data protection regulations.
Who are the top competitors of Sofar?
Sofar's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
What products or services does Sofar offer?
Sofar offers Pharmaceutical Production.
Who are Sofar's investors?
Sofar has 1 investor. Key investors include Alfasigma.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.